Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 421 entries
Sorted by: Best Match Show Resources per page
Liquid-handling Lego robots and experiments for STEM education and research

STEM education

Hyman L, Voitiuk K.
GSID: RfhVgIomXYIJ
LC Gerber, A Calasanz-Kaiser, L Hyman, K Voitiuk… - PLoS …, 2017 - journals.plos.org

… While playful robotics such as Lego Mindstorms significantly support education initiatives in mechatronics … Education EV3 core set alone, and this publication includes building and experiment instructions to set the stage for dissemination and further development in education...

Cite
Gerber, L. C., Calasanz-Kaiser, A., Hyman, L., Voitiuk, K., Patil, U., & Riedel-Kruse, I. H. (2017). Liquid-handling Lego robots and experiments for STEM education and research. PLoS biology, 15(3), e2001413.
Gerber, Lukas C., et al. "Liquid-handling Lego robots and experiments for STEM education and research." PLoS biology 15.3 (2017): e2001413.
Copy Download .nbib Format: MLA
Mandibular reconstruction using an axially vascularized tissue-engineered construct.

Annals of surgical innovation and research

Eweida AM, Nabawi AS, Marei MK, Khalil MR, Elhammady HA.
PMID: 21418603
Ann Surg Innov Res. 2011 Mar 20;5:2. doi: 10.1186/1750-1164-5-2.

BACKGROUND: Current reconstructive techniques for continuity defects of the mandible include the use of free flaps, bone grafts, and alloplastic materials. New methods of regenerative medicine designed to restore tissues depend mainly on the so-called extrinsic neovascularization, where the...

Cite
Eweida AM, Nabawi AS, Marei MK, et al. Mandibular reconstruction using an axially vascularized tissue-engineered construct. Ann Surg Innov Res. 2011;5:2doi: 10.1186/1750-1164-5-2.
Eweida, A. M., Nabawi, A. S., Marei, M. K., Khalil, M. R., & Elhammady, H. A. (2011). Mandibular reconstruction using an axially vascularized tissue-engineered construct. Annals of surgical innovation and research, 52. https://doi.org/10.1186/1750-1164-5-2
Eweida, Ahmad M, et al. "Mandibular reconstruction using an axially vascularized tissue-engineered construct." Annals of surgical innovation and research vol. 5 (2011): 2. doi: https://doi.org/10.1186/1750-1164-5-2
Eweida AM, Nabawi AS, Marei MK, Khalil MR, Elhammady HA. Mandibular reconstruction using an axially vascularized tissue-engineered construct. Ann Surg Innov Res. 2011 Mar 20;5:2. doi: 10.1186/1750-1164-5-2. PMID: 21418603; PMCID: PMC3069948.
Copy Download .nbib Format: NLM
The endolysin from the Enterococcus faecalis bacteriophage VD13 and conditions stimulating its lytic activity.

FEMS microbiology letters

Swift SM, Rowley DT, Young C, Franks A, Hyman P, Donovan DM.
PMID: 27634307
FEMS Microbiol Lett. 2016 Oct 01;363(19). doi: 10.1093/femsle/fnw216.

Bacteriophages produce endolysins (peptidoglycan hydrolases) to lyse the host cell from within and release nascent bacteriophage particles. Recombinant endolysins can lyse Gram-positive bacteria when added exogenously. As a potential alternative antimicrobial, we cloned and expressed the enterococcal VD13 bacteriophage...

Cite
Swift SM, Rowley DT, Young C, et al. The endolysin from the Enterococcus faecalis bacteriophage VD13 and conditions stimulating its lytic activity. FEMS Microbiol Lett. 2016;363(19)doi: 10.1093/femsle/fnw216.
Swift, S. M., Rowley, D. T., Young, C., Franks, A., Hyman, P., & Donovan, D. M. (2016). The endolysin from the Enterococcus faecalis bacteriophage VD13 and conditions stimulating its lytic activity. FEMS microbiology letters, 363(19), . https://doi.org/10.1093/femsle/fnw216
Swift, Steven M, et al. "The endolysin from the Enterococcus faecalis bacteriophage VD13 and conditions stimulating its lytic activity." FEMS microbiology letters vol. 363,19 (2016). doi: https://doi.org/10.1093/femsle/fnw216
Swift SM, Rowley DT, Young C, Franks A, Hyman P, Donovan DM. The endolysin from the Enterococcus faecalis bacteriophage VD13 and conditions stimulating its lytic activity. FEMS Microbiol Lett. 2016 Oct 01;363(19). doi: 10.1093/femsle/fnw216. PMID: 27634307.
Copy Download .nbib Format: NLM
Risk of failure of primary hip arthroscopy-a population-based study.

Journal of hip preservation surgery

Degen RM, Pan TJ, Chang B, Mehta N, Chamberlin PD, Ranawat AS, Nawabi DH, Kelly BT, Lyman S.
PMID: 28948033
J Hip Preserv Surg. 2017 Jun 26;4(3):214-223. doi: 10.1093/jhps/hnx018. eCollection 2017 Aug.

The aims of this study are (i) to report on the rates of subsequent surgery following hip arthroscopy and (ii) to identify prognostic variables associated with revision surgery, survival rates and complication rates. The Statewide Planning and Research Cooperative...

Cite
Degen RM, Pan TJ, Chang B, et al. Risk of failure of primary hip arthroscopy-a population-based study. J Hip Preserv Surg. 2017;4(3):214-223doi: 10.1093/jhps/hnx018.
Degen, R. M., Pan, T. J., Chang, B., Mehta, N., Chamberlin, P. D., Ranawat, A. S., Nawabi, D. H., Kelly, B. T., & Lyman, S. (2017). Risk of failure of primary hip arthroscopy-a population-based study. Journal of hip preservation surgery, 4(3), 214-223. https://doi.org/10.1093/jhps/hnx018
Degen, Ryan M, et al. "Risk of failure of primary hip arthroscopy-a population-based study." Journal of hip preservation surgery vol. 4,3 (2017): 214-223. doi: https://doi.org/10.1093/jhps/hnx018
Degen RM, Pan TJ, Chang B, Mehta N, Chamberlin PD, Ranawat AS, Nawabi DH, Kelly BT, Lyman S. Risk of failure of primary hip arthroscopy-a population-based study. J Hip Preserv Surg. 2017 Jun 26;4(3):214-223. doi: 10.1093/jhps/hnx018. eCollection 2017 Aug. PMID: 28948033; PMCID: PMC5604179.
Copy Download .nbib Format: NLM
Finding evidence about the costs of palliative care: CareSearch's suite of search tools.

Palliative medicine

Hayman S, Tieman J.
PMID: 28281404
Palliat Med. 2017 Apr;31(4):387-388. doi: 10.1177/0269216316673551. Epub 2016 Oct 26.

No abstract available.

Cite
Hayman S, Tieman J. Finding evidence about the costs of palliative care: CareSearch's suite of search tools. Palliat Med. 2016;31(4):387-388doi: 10.1177/0269216316673551.
Hayman, S., & Tieman, J. (2017). Finding evidence about the costs of palliative care: CareSearch's suite of search tools. Palliative medicine, 31(4), 387-388. https://doi.org/10.1177/0269216316673551
Hayman, Sarah, and Tieman, Jennifer. "Finding evidence about the costs of palliative care: CareSearch's suite of search tools." Palliative medicine vol. 31,4 (2017): 387-388. doi: https://doi.org/10.1177/0269216316673551
Hayman S, Tieman J. Finding evidence about the costs of palliative care: CareSearch's suite of search tools. Palliat Med. 2017 Apr;31(4):387-388. doi: 10.1177/0269216316673551. Epub 2016 Oct 26. PMID: 28281404.
Copy Download .nbib Format: NLM
Inflammatory bowel disease and anxiety: links, risks, and challenges faced.

Clinical and experimental gastroenterology

Bannaga AS, Selinger CP.
PMID: 25848313
Clin Exp Gastroenterol. 2015 Mar 23;8:111-7. doi: 10.2147/CEG.S57982. eCollection 2015.

Inflammatory bowel disease (IBD) causes severe physical symptoms and is also associated with psychological comorbidities. Abnormal anxiety levels are found in up to 40% of patients with IBD. Anxiety symptoms are often related to flares of IBD but may...

Cite
Bannaga AS, Selinger CP. Inflammatory bowel disease and anxiety: links, risks, and challenges faced. Clin Exp Gastroenterol. 2015;8:111-7doi: 10.2147/CEG.S57982.
Bannaga, A. S., & Selinger, C. P. (2015). Inflammatory bowel disease and anxiety: links, risks, and challenges faced. Clinical and experimental gastroenterology, 8111-7. https://doi.org/10.2147/CEG.S57982
Bannaga, Ayman S, and Selinger, Christian P. "Inflammatory bowel disease and anxiety: links, risks, and challenges faced." Clinical and experimental gastroenterology vol. 8 (2015): 111-7. doi: https://doi.org/10.2147/CEG.S57982
Bannaga AS, Selinger CP. Inflammatory bowel disease and anxiety: links, risks, and challenges faced. Clin Exp Gastroenterol. 2015 Mar 23;8:111-7. doi: 10.2147/CEG.S57982. eCollection 2015. PMID: 25848313; PMCID: PMC4376063.
Copy Download .nbib Format: NLM
Two Year Clinical Outcomes of Total Hip Arthroplasty Are Not Dependent on Femoral Head Composition.

HSS journal : the musculoskeletal journal of Hospital for Special Surgery

Ast MP, Lyman S, Gorab AH, Parkes N, Boles J, Lee YY, Westrich GH.
PMID: 26140032
HSS J. 2015 Jul;11(2):130-5. doi: 10.1007/s11420-015-9433-0. Epub 2015 Mar 20.

BACKGROUND: Assessment of clinical outcomes and patient quality of life after total hip arthroplasty continues to grow in importance with the focus on how bearing surfaces affect long-term survival, wear, and cost. Further, as quality measures have become incorporated...

Cite
Ast MP, Lyman S, Gorab AH, et al. Two Year Clinical Outcomes of Total Hip Arthroplasty Are Not Dependent on Femoral Head Composition. HSS J. 2015;11(2):130-5doi: 10.1007/s11420-015-9433-0.
Ast, M. P., Lyman, S., Gorab, A. H., Parkes, N., Boles, J., Lee, Y. Y., & Westrich, G. H. (2015). Two Year Clinical Outcomes of Total Hip Arthroplasty Are Not Dependent on Femoral Head Composition. HSS journal : the musculoskeletal journal of Hospital for Special Surgery, 11(2), 130-5. https://doi.org/10.1007/s11420-015-9433-0
Ast, Michael P, et al. "Two Year Clinical Outcomes of Total Hip Arthroplasty Are Not Dependent on Femoral Head Composition." HSS journal : the musculoskeletal journal of Hospital for Special Surgery vol. 11,2 (2015): 130-5. doi: https://doi.org/10.1007/s11420-015-9433-0
Ast MP, Lyman S, Gorab AH, Parkes N, Boles J, Lee YY, Westrich GH. Two Year Clinical Outcomes of Total Hip Arthroplasty Are Not Dependent on Femoral Head Composition. HSS J. 2015 Jul;11(2):130-5. doi: 10.1007/s11420-015-9433-0. Epub 2015 Mar 20. PMID: 26140032; PMCID: PMC4481248.
Copy Download .nbib Format: NLM
Identification of the Transmembrane Glucose Regulated Protein 78 as a Biomarker for the Brain Cancer Glioblastoma Multiforme by Gene Expression and Proteomic Studies.

Journal of membrane science & technology

Banerjee HN, Hyman G, Evans S, Manglik V, Gwebu E, Banerjee A, Vaughan D, Medley J, Krauss C, Wilkins J, Smith V, Banerji A, Rousch J.
PMID: 26207187
J Membr Sci Technol. 2014 Feb 15;4(1). doi: 10.4172/2155-9589.1000126.

The prognosis of patients with Glioblastoma Multiforme (GBM), the most malignant adult glial brain tumor, remains poor in spite of advances in treatment procedures, including surgical resection, irradiation and chemotherapy. Genetic heterogeneity of GBM warrants extensive studies to gain...

Cite
Banerjee HN, Hyman G, Evans S, et al. Identification of the Transmembrane Glucose Regulated Protein 78 as a Biomarker for the Brain Cancer Glioblastoma Multiforme by Gene Expression and Proteomic Studies. J Membr Sci Technol. 2014;4(1)doi: 10.4172/2155-9589.1000126.
Banerjee, H. N., Hyman, G., Evans, S., Manglik, V., Gwebu, E., Banerjee, A., Vaughan, D., Medley, J., Krauss, C., Wilkins, J., Smith, V., Banerji, A., & Rousch, J. (2014). Identification of the Transmembrane Glucose Regulated Protein 78 as a Biomarker for the Brain Cancer Glioblastoma Multiforme by Gene Expression and Proteomic Studies. Journal of membrane science & technology, 4(1), . https://doi.org/10.4172/2155-9589.1000126
Banerjee, H N, et al. "Identification of the Transmembrane Glucose Regulated Protein 78 as a Biomarker for the Brain Cancer Glioblastoma Multiforme by Gene Expression and Proteomic Studies." Journal of membrane science & technology vol. 4,1 (2014). doi: https://doi.org/10.4172/2155-9589.1000126
Banerjee HN, Hyman G, Evans S, Manglik V, Gwebu E, Banerjee A, Vaughan D, Medley J, Krauss C, Wilkins J, Smith V, Banerji A, Rousch J. Identification of the Transmembrane Glucose Regulated Protein 78 as a Biomarker for the Brain Cancer Glioblastoma Multiforme by Gene Expression and Proteomic Studies. J Membr Sci Technol. 2014 Feb 15;4(1). doi: 10.4172/2155-9589.1000126. PMID: 26207187; PMCID: PMC4508859.
Copy Download .nbib Format: NLM
On recalls.

Biomedical instrumentation & technology

Hyman W.
PMID: 25621636
Biomed Instrum Technol. 2015 Jan-Feb;49(1):3. doi: 10.2345/0899-8205-49.1.3.

No abstract available.

Cite
Hyman W. On recalls. Biomed Instrum Technol. 2015;49(1):3doi: 10.2345/0899-8205-49.1.3.
Hyman, W. (2015). On recalls. Biomedical instrumentation & technology, 49(1), 3. https://doi.org/10.2345/0899-8205-49.1.3
Hyman, William. "On recalls." Biomedical instrumentation & technology vol. 49,1 (2015): 3. doi: https://doi.org/10.2345/0899-8205-49.1.3
Hyman W. On recalls. Biomed Instrum Technol. 2015 Jan-Feb;49(1):3. doi: 10.2345/0899-8205-49.1.3. PMID: 25621636.
Copy Download .nbib Format: NLM
A unique, interactive and web-based pediatric rheumatology teaching module: residents' perceptions.

Pediatric rheumatology online journal

Batthish M, Bassilious E, Schneider R, Feldman BM, Hyman A, Tse SM.
PMID: 23710693
Pediatr Rheumatol Online J. 2013 May 27;11(1):22. doi: 10.1186/1546-0096-11-22.

BACKGROUND: The limited availability of pediatric rheumatologists for teaching in pediatric residency programs negatively impacts resident education about rheumatology. At present, there are no educational websites available for trainees to learn about pediatric rheumatology. We are planning to develop...

Cite
Batthish M, Bassilious E, Schneider R, et al. A unique, interactive and web-based pediatric rheumatology teaching module: residents' perceptions. Pediatr Rheumatol Online J. 2013;11(1):22doi: 10.1186/1546-0096-11-22.
Batthish, M., Bassilious, E., Schneider, R., Feldman, B. M., Hyman, A., & Tse, S. M. (2013). A unique, interactive and web-based pediatric rheumatology teaching module: residents' perceptions. Pediatric rheumatology online journal, 11(1), 22. https://doi.org/10.1186/1546-0096-11-22
Batthish, Michelle, et al. "A unique, interactive and web-based pediatric rheumatology teaching module: residents' perceptions." Pediatric rheumatology online journal vol. 11,1 (2013): 22. doi: https://doi.org/10.1186/1546-0096-11-22
Batthish M, Bassilious E, Schneider R, Feldman BM, Hyman A, Tse SM. A unique, interactive and web-based pediatric rheumatology teaching module: residents' perceptions. Pediatr Rheumatol Online J. 2013 May 27;11(1):22. doi: 10.1186/1546-0096-11-22. PMID: 23710693; PMCID: PMC3679723.
Copy Download .nbib Format: NLM
The success of extracorporeal shock-wave lithotripsy based on the stone-attenuation value from non-contrast computed tomography.

Arab journal of urology

Massoud AM, Abdelbary AM, Al-Dessoukey AA, Moussa AS, Zayed AS, Mahmmoud O.
PMID: 26019941
Arab J Urol. 2014 Jun;12(2):155-61. doi: 10.1016/j.aju.2014.01.002. Epub 2014 Feb 16.

OBJECTIVE: To determine the utility of the urinary stone-attenuation value (SAV, in Hounsfield units, HU) from non-contrast computed tomography (NCCT) for predicting the success of extracorporeal shock-wave lithotripsy (ESWL).PATIENTS AND METHODS: The study included 305 patients with renal calculi...

Cite
Massoud AM, Abdelbary AM, Al-Dessoukey AA, et al. The success of extracorporeal shock-wave lithotripsy based on the stone-attenuation value from non-contrast computed tomography. Arab J Urol. 2014;12(2):155-61doi: 10.1016/j.aju.2014.01.002.
Massoud, A. M., Abdelbary, A. M., Al-Dessoukey, A. A., Moussa, A. S., Zayed, A. S., & Mahmmoud, O. (2014). The success of extracorporeal shock-wave lithotripsy based on the stone-attenuation value from non-contrast computed tomography. Arab journal of urology, 12(2), 155-61. https://doi.org/10.1016/j.aju.2014.01.002
Massoud, Amr M, et al. "The success of extracorporeal shock-wave lithotripsy based on the stone-attenuation value from non-contrast computed tomography." Arab journal of urology vol. 12,2 (2014): 155-61. doi: https://doi.org/10.1016/j.aju.2014.01.002
Massoud AM, Abdelbary AM, Al-Dessoukey AA, Moussa AS, Zayed AS, Mahmmoud O. The success of extracorporeal shock-wave lithotripsy based on the stone-attenuation value from non-contrast computed tomography. Arab J Urol. 2014 Jun;12(2):155-61. doi: 10.1016/j.aju.2014.01.002. Epub 2014 Feb 16. PMID: 26019941; PMCID: PMC4434685.
Copy Download .nbib Format: NLM
Coherence analysis discriminates between retroviral integration patterns in CD34(+) cells transduced under differing clinical trial conditions.

Molecular therapy. Methods & clinical development

Hallwirth CV, Garg G, Peters TJ, Kramer BA, Malani NV, Hyman J, Ruan X, Ginn SL, Hetherington NA, Veeravalli L, Shahab A, Ranganathan S, Wei CL, Liddle C, Thrasher AJ, Bushman FD, Buckley MJ, Alexander IE.
PMID: 26029726
Mol Ther Methods Clin Dev. 2015 Apr 29;2:15015. doi: 10.1038/mtm.2015.15. eCollection 2015.

Unequivocal demonstration of the therapeutic utility of γ-retroviral vectors for gene therapy applications targeting the hematopoietic system was accompanied by instances of insertional mutagenesis. These events stimulated the ongoing development of putatively safer integrating vector systems and analysis methods...

Cite
Hallwirth CV, Garg G, Peters TJ, et al. Coherence analysis discriminates between retroviral integration patterns in CD34(+) cells transduced under differing clinical trial conditions. Mol Ther Methods Clin Dev. 2015;2:15015doi: 10.1038/mtm.2015.15.
Hallwirth, C. V., Garg, G., Peters, T. J., Kramer, B. A., Malani, N. V., Hyman, J., Ruan, X., Ginn, S. L., Hetherington, N. A., Veeravalli, L., Shahab, A., Ranganathan, S., Wei, C. L., Liddle, C., Thrasher, A. J., Bushman, F. D., Buckley, M. J., & Alexander, I. E. (2015). Coherence analysis discriminates between retroviral integration patterns in CD34(+) cells transduced under differing clinical trial conditions. Molecular therapy. Methods & clinical development, 215015. https://doi.org/10.1038/mtm.2015.15
Hallwirth, Claus V, et al. "Coherence analysis discriminates between retroviral integration patterns in CD34(+) cells transduced under differing clinical trial conditions." Molecular therapy. Methods & clinical development vol. 2 (2015): 15015. doi: https://doi.org/10.1038/mtm.2015.15
Hallwirth CV, Garg G, Peters TJ, Kramer BA, Malani NV, Hyman J, Ruan X, Ginn SL, Hetherington NA, Veeravalli L, Shahab A, Ranganathan S, Wei CL, Liddle C, Thrasher AJ, Bushman FD, Buckley MJ, Alexander IE. Coherence analysis discriminates between retroviral integration patterns in CD34(+) cells transduced under differing clinical trial conditions. Mol Ther Methods Clin Dev. 2015 Apr 29;2:15015. doi: 10.1038/mtm.2015.15. eCollection 2015. PMID: 26029726; PMCID: PMC4445430.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 421 entries